Cargando…
Boosting Bismuth(III) Complexation for Targeted α‐Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA
Targeted α therapy (TAT) is a promising tool in the therapy of cancer. The radionuclide (213)Bi(III) shows favourable physical properties for this application, but the fast and stable chelation of this metal ion remains challenging. Herein, we demonstrate that the mesocyclic chelator AAZTA quickly c...
Autores principales: | Horváth, Dávid, Vágner, Adrienn, Szikra, Dezsö, Trencsényi, György, Demitri, Nicola, Guidolin, Nicol, Maiocchi, Alessandro, Ghiani, Simona, Travagin, Fabio, Giovenzana, Giovanni B., Baranyai, Zsolt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828418/ https://www.ncbi.nlm.nih.gov/pubmed/36073561 http://dx.doi.org/10.1002/anie.202207120 |
Ejemplares similares
-
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications
por: Fersing, Cyril, et al.
Publicado: (2022) -
Equilibrium Thermodynamics, Formation, and Dissociation Kinetics of Trivalent Iron and Gallium Complexes of Triazacyclononane-Triphosphinate (TRAP) Chelators: Unraveling the Foundations of Highly Selective Ga-68 Labeling
por: Vágner, Adrienn, et al.
Publicado: (2018) -
The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation
por: Potor, László, et al.
Publicado: (2020) -
AAZTA(5)/AAZTA(5)-TOC: synthesis and radiochemical evaluation with (68)Ga, (44)Sc and (177)Lu
por: Sinnes, Jean-Philippe, et al.
Publicado: (2019) -
Surprising Complexity of the [Gd(AAZTA)(H(2)O)(2)](−) Chelate Revealed by NMR in the
Frequency and Time Domains
por: Lalli, Daniela, et al.
Publicado: (2021)